The global pathological microscopes market size is estimated to accrue USD 523.20 million by 2023, states Market Research Future (MRFR) in its latest report. Increasing prevalence of various diseases is the primary driver of the market. High incidence of cancer, tuberculosis, and diabetes among adults and children has called for advanced diagnostic procedures which can detect the symptoms at an early stage. This is expected to bolster the demand of the pathological microscopes market share among its end-users. The market can exhibit 4.50% CAGR over the forecast period (2018-2023).

Drug discovery and development is an emerging area which requires microscopes for expediting the commercialization of products. Customized solutions offered by microscope manufacturers to minimize the iteration of assays and streamline the workflow is likely to work in the market’s favor. Funding by pharmaceutical companies can offer new opportunities to players. This is evident by the spending budget of USD 149.8 billion by the International Federation of Pharmaceutical Manufacturers & Associations in 2015.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/7319

Automation of laboratories which includes devices that gel with advanced technologies such as augmented reality which expands the image size and resolution is likely to boost market demand. In addition, emergence of various public and private diagnostic centers for testing of diseases is touted to augur well for the pathological microscopes market. These centers serve as a focal point for testing of various diseases and reducing the burden of patients on hospitals.

High purchase and maintenance costs of microscopes can pose a challenge to the market. In addition, unfavorable reimbursement schemes which cover only government-run diagnostic centers can restrain market growth.

Competitive Analysis:

Eminent names in the pathological microscopes market are Leica Biosystems Nussloch GmbH (Germany), Sakura Finetek USA, Inc. (U.S.), ZEISS International (Germany), Celestron LLC (U.S.), Euromex Microscopen BV (The Netherlands), Olympus Corporation (Japan), Bruker Corporation (U.S.), Labomed, Inc. (U.S.), Nikon Corporation (Japan), and Hitachi High-Technologies Corporation (Japan).

Segmentation:

The pathological microscopes market is segmented by type, application, and end-user.

By Type, electron microscope held close to 41.4% share in 2017, followed by optical microscope (18.8%), compound microscope (13.5%), digital microscope (5.4%), fluorescence microscope (4.4%), and others (16.5%). Electron microscopes can generate nearly USD 217.81 million by 2023 owing to their application in life sciences. Prevalence of diseases such as anemia and leukemia which require the need of electron microscopes lend credence to the segment valuation. But digital microscopes can exhibit the highest CAGR of 5.01% during the forecast period to accumulate USD 28.90 million for the pathological microscopes market by 2023.
By Application, bodily fluids accounted for 79.4% share of the pathological microscopes market in 2017, followed by tissue scanning (12.7%), and others (7.9%). Bodily fluids can generate USD 418.84 million for the pathological microscopes market by 2023. This can be attributed to use of fluid samples to identify the presence of diseases such as tuberculosis in the human body. High prevalence of blood disorders is driving the segment growth. On the other hand, tissue scanning is touted to accumulate USD 67.94 million by 2023. High prevalence of cancer and use of digital microscopes to detect abnormal tissue growth can fuel the segment growth.
By End-user, pathology & diagnostic laboratories accounted for 45.2% market share in 2017, followed by hospitals & clinics (38.6%), forensic laboratories (11.5%), and others (4.7%). Hospitals & clinics will be the biggest end-user of the pathological microscopes market by 2023. It can generate USD 206.25 million by the end of the forecast period owing to the setup of various branches of hospital chains to handle high patient volume. On the other hand, pathology & diagnostic laboratories can generate USD 239.73 million by 2023 thanks to possessing various skilled personnel and use of hematology, clinical microbiology, and molecular pathology for rapid diagnosis of diseases.
Regional Analysis:

Region-wise segmentation of the pathological microscopes market includes Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas accounted for 37.5% market share in 2017, followed by APAC (35%), Europe (20.1%), and MEA (7.4%).

Get Access Full Report @ https://www.marketresearchfuture.com/reports/pathological-microscopes-market-7319

The Americas pathological microscopes market can reach a size of USD 190.98 million by 2023 owing to the uptick noticed in the setup of research and academic institutes. High incidence of chronic diseases coupled with investments in research and development (R&D) are factors expected to bolster market demand till 2023.

The APAC region is expected to generate USD 192.58 million by 2023, at a CAGR of 5.36% during the forecast period. Abundance of researchers coupled with investments in research and development are likely to bolster market demand by 2023. Presence of players such as Olympus and Nikon in Japan are expected to expedite the development of microscopes.

On the other hand, the Europe pathological microscopes market owing to rapid expansion of the life sciences sector. In addition, funding by governments and rise of public-private partnerships to accelerate development of drugs is expected to push its size to USD 103.99 million by 2023.